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ABSTRACT
Ferro sulphate (FeSO
4
) overload and carbon tetrachloride (CCl
4
) are chemical hepatocarcinogen. Ferro sulphate
disrupts the redox balance of the cell and generates chronic oxidative stress by which modulates signaling networks
related to malignant transformation. Meanwhile CCl
4
induces hepatic damage in lipid peroxidation and decreases
activities of antioxidant enzymes and generation of free radicals. The aim of this study is to investigate the effect of
a pause of chemical hepatocarcinogen induced in Rattus norvegicus rats. Two months old adult maleRattus norvegicus
rats weighing around 110–191 g were used. The rats were divided into three groups. In group I (n=3), no-treatment
control; in group II (n=3), rats were fed 3.5% FeSO4 in the diet together with 0.1 ml/ kgBW CCl4 administered by
gavage per os 5 days a week for 3 weeks. However, in group III (n=3), rats were administered by chemical
hepatocarcinogen like group I then continued with no-treatment for 2 weeks (a pause of 2 weeks was inserted).
Body weight were determined per week. At the end of the experiment, rats were fasted overnight, and then 3.0 ml
of blood was drawn from the rats from the vena orbitalis in EDTA-tube and then sacrificed. Liver and body weight of
rats were determined for each group. Plasma was prepared to biochemical estimation of different parameters like
total protein (TP), non-functional plasma enzymes: aspartate aminotransferase (AST), alanine aminotransferase
(ALT), and gamma glutamyl transferase (GT) by biochemical test kits in SYNCHRON CX® System(s). The liver
tissue was used for histological and immunohistochemical assessment. All data were analyzed with one-way ANOVA,
p < 0.05 for the statistical comparison of groups in Matrix Laboratory (MATLAB) programs in Microsoft Windows
XP.According to the research results of the body weight on treated group gained significantly less body weight than
control group (p= 0.00). Liver weight at the end of the experiment were significantly decreased in treated group
compared to control (p=0.00); but Liver/ Body weight ratio were significantly increased in treated group compared
to control (p=0.00). The blood plasma were significant differences in the values of TP andGT (p = 0.00 and
0.00), but the values of AST, ALT, and ratio of AST to ALT were not significant differences (p = 0.62, 0.67, and
0.26 respectively). Histopathological studies of the liver section of treated group showed the damage of the liver
cells. In the group of a pause of chemical hepatocarcinogen induced in rats were no major morphological changes
were observed compared to group that administered for 3 weeks, except for decreased steatosis level. An overall
decrease in vacuoles at the group of a pause suggested a change metabolism and toxin depletion over time. Furthermore,
p53 immunohistochemistry on 9 cases revealed no p53 mutations or protein overexpression. It was concluded that
p-53 mutation was not detected in Rattus norvegicus rats that induced hepatocarcinogenic agent FeSO4 3.5% and
CCl
4
0.1 ml/ kg BW for 3 weeks and hepatic injury still encountered in a pause of chemical hepatocarcinogen
induced showed that the recovery was not complete.
Key words: pause of chemical hepatocarcinogen induced - Rattus norvegicus - liver tissue - total protein - non-
functional plasma enzymes
INTRODUCTION
Liver disorders are one of the world health
problems. Despite its frequent occurrence, high
morbidity and high mortality, its medical
management is currently in adequate. So far not
yet any therapy has successfully prevented the
progression of hepatic disease. Liver injury due to
chemicals or infectious agents may lead to
progressive liver fibrosis and ultimately cirrhosis and
liver failure.1
Iron is a component of several metaloproteins
and plays a crucial role in vital biochemical activities,
such as oxygen sensing and transport, electron
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transfer, and catalysis.2 Iron is thus indispensable
for life. The biological functions of iron are based
on its chemical properties, e.g., its capacity to form
a variety of coordination complexes with organic
ligands in a dynamic and flexible mode, and its
favorable redox potential to switch between the
ferrous, Fe(II), and ferric, Fe(III). The
bioavailability of iron is generally limited, because
under aerobic conditions, Fe(II) is readily oxidized
in solution to Fe(III), which is virtually insoluble at
physiological pH. However, because human beings
have no active mechanism to control iron excretion,
excess iron, regardless of the route of entry,
accumulates in parenchymal organs and threatens
cell viability.3 Iron overload arises from a sustained
increase in iron supply over iron requirements and
develops with conditions in which the regulation of
intestinal iron absorption is altered (hereditary
hemochromatosis, refractory anemia with ineffective
erythropoiesis), bypassed (transfusional iron
overload), or both.4 Iron overload results primarily
in an increase in storage iron held in ferritin and
hemosiderin; 5 functional iron is little affected.
Whether derived from increased absorption of
dietary iron or from transfused red blood cells,
progressive iron accumulation eventually
overwhelms the body’s capacity for safe
sequestration of the excess. In addition, there are
many diseases that show mild iron deposition or
dysregulation of body iron distribution. Such
conditions include chronic hepatitis C, alcoholic liver
disease and non-alcoholic Steatohepatitis. Indeed,
when iron-buffering capability is overwhelmed,
oxidative stress-induced cell damage may arise,
mainly in the liver, the main storage site for iron in
the body.6
Carbon tetrachloride is a selective hepatotoxic
chemical agent. Liver cell injury induced by CCl
4
involves initially the metabolism of CCl 4 to
trichloromethyl free-radical by the mixed function
oxidase system of the endoplasmic reticulum. It is
postulated that secondary mechanisms link CCl
4
metabolism to the widespread disturbances in
hepatocyte function. These secondary mechanisms
could involve the generation of toxic products arising
directly from CCl
4
metabolism or from peroxidative
degeneration of membrane lipids. The possible
involvementof radical species suchas trichloromethyl
(CC
l3
), trichloromethylperoxy (OOCC
l3
), and
chlorine (Cl) free radicals, as well as phosgene and
aldehydic products of lipid peroxidation, as toxic
intermediates is discussed. Data do not support the
view that an increase in cytosolic free calcium is
important in the toxic action of CCl
4
or
bromotrichloromethane. In addition, CCl
4
induced
inhibition of very low density lipoprotein secretion
by hepatocytes is not a result of elevated levels of
cytosolic freecalcium.7Carbon tetrachloride causes
hepatic injury, including hepatocytic necrosis,
steatosis, and inflammation. Low-dose and long-
term administration of CC
l4
induces hepatic
fibrogenesis, which largely imitates hepatic fibrosis
in humandiseases.8
The aims of this study is to investigate the effects
of a pause of chemical hepatocarcinogen induced in
body and liver weight, plasma total protein, non-
functional plasma enzymes and histological changes
using experimental animal model.
MATERIALS AND METHODS
The chemical hepatocarcinogenic agents used
in this experiment were FeSO
4
and CCl
4
. Water and
basal feed were given ad libitum. Basal feed contain
maizena (54.0%), skim milk (40.0%), CaCO 3
(1.5%), KH2PO4 (0.5%), NaCl (0.3%), MgSO4
(0.1%), vitamin B compleks (0.3%), vitamin D
(0.2%), vitamin K (0.0001%), maize oil (2.4%),
FeSO
4
(0.1%), vitamin E (0.012%), and vitamin A
(0.1%).9
Animals and surgery
In this study, 9 adult male Rattus norvegicus
rats, (2.0 months old) fromAnimal Laboratory Care
Unit Gadjah Mada University, weighing 110–191 g
were used. The rats were divided into three groups.
In group I (n=3), no-treatment control; in group II
(n=3), rats were fed 3.5% FeSO
4
in the diet together
with 0.1 ml/ kgBW CCl
4
administered by gavage
per os 5 days a week for 3 weeks. However, in
group III (n=3), rats were administered by chemical
hepatocarcinogen like group II then continued with
no-treatment for 2 weeks (a pause of 2 weeks was
inserted). Body weight were determined per week.
At the end of the experiment, rats were fasted
overnight, and then 3.0 ml of blood was drawn from
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the rats from the vena orbitalis in EDTA-tube and
then sacrificed. Liver and body weight of rats were
determined for each group.
Laboratory Assays
Plasma was prepared for biochemical analysis
of different parameters such as total protein (TP),
non-functional plasma enzymes: aspartate
aminotransferase (AST), alanine aminotransferase
(ALT), and gamma glutamyl transferase (GT) by
biochemical test kits in SYNCHRONCX®
System(s) (Chemistry Information Sheet 389775
AD and 389745 AD).
Histology
The fixed specimens were dehydrated, cleared,
and embedded in paraffin. The serial 6 sections,
which were 5 ìm thick, were taken from these blocks
by classic rotary microtome and put onto poly-L-
lysine-coated slides for immunohistochemistry.
Immunohistochemistry
For immunohistochemistry, six 5 m-thick
serial sections were cut. These slides were
deparaffinized in 65°C in an incubator without
incubation. They were then rehydrated by
decreasing alcohol series. After rehydration, three
of the slides were stained for p53 expression. All
the slides were evaluated under light microscope (a
BX51TF Olympus optical microscope).
Statistical analysis
All data were analyzed with one-way ANOVA
for the statistical comparison of groups in Matrix
Laboratory (MATLAB) programs in Microsoft
Windows XP. A p value of less than 0.05 was
accepted as statistically significant.
RESULTS AND DISCUSSIONS
In Group II, the average of iron overload that
consumed by rats = 0.18 ± 0.01 mg/ kgBW for 5
days/ week. Next day (2 days), the average of
normal iron (0.1% FeSO
4
) that consumed = 0.005
± 0.001 mg/kgBW. Under normal circumstances,
the body guards its content of iron zealously,
therefore a healthy 70-kg adult male loses only about
1 mg/ d (= 0.002 mg/kgBW).10 Iron absorption
refers to the amount of dietary iron that the body
obtains and uses from food. Healthy adults absorb
about 10% to 15% of dietary iron. Therefore 5 day a
week, rats were fed excess iron in the diet (= 90-fold
than required). For next day (2 day a week), rats were
fed less iron in the diet(= 0.25-fold than required).
In Group III, the average of iron overload that
consumed by rats = 0.08 ± 0.03 mg/ kgBW for 5
days/ week for 3 weeks. The next day, average of
normal iron that consumed = 0.002 ± 0.001 mg/
kgBW. So for 5 day a week, rats were fed excess
iron in the diet (=40-fold than required). For next
day (2 days a week), rats were fed less iron in the
diet (= 0.1-fold than required). For next week (2
weeks), average of normal iron that consumed =
0.003 ± 0.0009 mg/ kgBW, so rats were feed less
iron in the diet (= 0.3-fold than required).
Excess iron consumed over a period of time
can result in toxicity and even death. The
mechanisms for iron-induced neoplastic
transformation are poorly characterized. It is clear
that iron overload disrupts the redox balance of the
cell and generates chronic oxidative stress, which
modulates signaling networks related to malignant
transformation.11 The principle effect of CCl4 is
induced hepatic damage in lipid peroxidation and
decreased activities of antioxidant enzymes and
generation of free radicals. Tetrachloride-induced
hepatic fibrosis is a well-established animal model
to study the pathogenesis and therapy of chronic
liver injury.12 The potential of iron overload and
CCl4as a carcinogenic agent appears to be primarily
related to its ability to promote oxidative stress.
Body and liver weight, plasma total protein
and non-functional plasma enzymes
After treated with the hepatocarcinogen (FeSO4
and CCl4), all animals exhibited a change in their
body weight. However, animals on treated group
(Group II and III) gained significantly less body
weight than control group (Group I) (p=0.00). This
might be due to loss of appetite such an effect of
antiepileptic drugs as Lamotrigine induced decreased
body growth rate at toxic dose.20 Body and liver
weight, TP and non-functional plasma enzymes:
AST, ALT, andGT in experimental are shown in
TABLE 1.
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TABLE 1. Body and liver weight, liver/body weight ratio, TP and non-functional plasma enzymes:
GT, AST, ALT, and AST/ ALT ratio
in experimental.
Parameter Group
I (n = 3) II (n = 3) III (n = 3)
Body Weight (g) 198.0 ± 14.80 94.7 ± 4.93 72.7 ± 3.79*)
Liver Weight (g) 4.60 ± 0.529 2.63 ± 0.115 2.17 ± 0.1527*)
Liver/ Body weight ratio 0.023 ± 0.0036 0.028 ± 0.0003 0.030 ± 0.0016
*)
TP (g/ dl) 6.03 ± 0.321 5.69 ± 0.31 4.23 ± 0.091*)
GT (IU/ l) 1.63 ± 1.222 3.50 ± 1.000 13.37 ± 2.4542*)
ALT (IU/ l) 60.5 ± 12.28 54.7 ± 10.32 54.2 ± 3.54
AST (IU/ l) 118.0 ± 7.98 129.6 ± 16.75 122.5 ± 15.82
AST/ ALT ratio 2.00 ± 0.384 2.39 ± 0.189 2.26 ± 0.158
*)p<0.05 difference is statistically significant
Liver weight at the end of the experiment was
significantly decreased in treated group compared
to control (p=0.00); but Liver/ Body weight ratio
was significantly increased in treated group
compared to control (p=0.00). Varied factors may
be involved in the enlargement of the liver, and up
to this time only a few are known. The increase in
the percentage of water, as found by McEwen and
Haven, although only in limited amounts, seems to
be important. It suggests the possibility of systemic
changes in the cytoplasm. The suggestion of Yeakel
that the increase in liver size induced by hypertrophy
leading to an increased protein anabolism is still have
to be proved. Histological investigations indicate that
the increased weight of the liver may be explained
in part by a mitotic activity of the liver.13 The damage
of the liver caused by iron overload and CCl
4
was
evident by the alteration in serum marker enzymes
concentration beside the clinical signs and
histopathology, however, its exact mechanisms
remain unclear.14 Iron is essential for life but iron
overload was shown to be toxic and potentially fatal.
Hepatotoxicity is the most common finding in iron
over-load because liver is the main recipient of the
excess iron.12 However, it is known that when iron
is administered after the development of liver
dysfunction, fibrosis of the liver is accelerated and
increases the incidence of liver cirrhosis.15
The total protein after treatment with
hepatocarcinogenic agent (FeSO
4
3,5% and CCl
4
0,1 ml/ kgBW) were significantly lower compared
with those of the control group (p = 0.00). These
proteins are important liver function marker. The
concentration of plasma protein represents the
nutritional status, which is one of the factors
affecting the state of health of the animal.16 Protein
turnover is generally decreased with advanced liver
disease, mostly so in hepatic coma patients where
protein synthesis is only one third to one half of that
observedinnormal individuals.17Theliver isconsidered
to be the major source of plasma proteins, damage to
this organ leads to decrease of total protein.18-20 Since
total protein, globulin and albumin are averagely
responsive to total protein intake that the concentration
of serum protein at any given time is a function of the
nutritional status, water balance and other factors
affecting the state of health of the animal.21
Dietary steatohepatitis induced by administration
of hepatocarcinogenic agents was associated to an
increase in activity of GT. Observed values in
experimental (GroupIIandIII)weresignificantlyhigher
compared with those of the control group (p = 0.00);
thisenzymesignificantly increaseat toxic20.Abnormally
high activity ofGT appears to be specific for diseases
of the liver, biliary tract, and pancreas. It is an oncofetal
protein, a glycoprotein whose levels have been shown
to be altered during development and carcinogenesis.
Interest in GT has focused on its value in the
diagnosis of various liver diseases. The severity of
fatty liver can be evaluated using GT values as
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markers of serious hepatic dysfunction or damage.22
In most of liver diseases, both malignant and
nonmalignant, GT estimation has been reported
to be a sensitive but nonspecific indicator of the
disease. Recent studies from this laboratory have
shown a rise in activity of GT in patients with
head and neck cancer, as well.23
Activity ofALT andAST havebeen widely used
as sensitive laboratory parameters in clinical practice
to evaluate the degree of liver injury. Alanine
aminotransferase is an enzyme present in hepatocytes
(liver cells), and it leaks into blood when liver cells are
damaged.Alanine aminotransferase rises dramatically
in acute liver damage (such as viral hepatitis and
paracetamol overdose) and during liver inflammation.
Aspartate aminotransferase is similar toALT in that it
is another enzyme associated with liver parenchymal
cells. It is raised inacute liverdamageand isalsopresent
in red cells and cardiac muscle. Observed values in
this experiment showed there were no significant
differences in the values of AST and ALT (p = 0.62,
and 0.67 respectively). The serum values of these
enzymes do not correctly reflect the degree of hepatic
cell necrosis. Elevated activity of AST and ALT may
be observed when cells containing these enzymes are
injuredor thepermeabilityofcellmembranes increases.
Although serum levels of both ALT and AST are
elevated when liver cells are injured, the degree of
elevation is not parallel to the degree of injury.24 The
mechanismof theelevation isaffectedbymany factors,
such as etiology of the liver disease or severity of the
liver cell necrosis. The ratio ofAST toALT is a useful
parameter, which can predict the severity of liver
disease.25 Observed values of AST/ALT ratio in
experimental group wasalso not significantly different
compared with those of the control group (p=0.26).
When the ratio is over 2.0, alcoholic liver disease is
strongly suspected. The discrepancy in serum AST
and ALT remains controversial.24
Histopathological changes
Histopathological studies of the liver section of
control and experimental animals are shown in
FIGURE 1. The liver section of Group I (normal
Control) animals had normal architecture, where the
central veins, portal tracts, hepatocytes and
sinusoids appear normal. The lobular unit was also
well identified. The liver section of Group II showed
the damage of the liver cells. There were various
degrees of hydropic degeneration, individual
hepatocyte necrosis, hepatocellular fatty change
(steatosis), the cells were medium-sized, the nuclei
were polymorphic and varying in chromatin content,
along with other less significant structural changes
compared to control animals. The liver section of
Group III no major morphological changes were
observed compared to Group II, except for
decreased steatosis level. An overall decrease in
vacuoles at a pause (FeSO
4
and CCl
4
administered
for 3 weeks and no-treatment for 2 weeks) suggested
a change metabolism and toxin depletion over time.
Increased variance in hepatocyte size was observed
in livers from CCl
4
-treated animals, suggesting
cellular proliferation, a marker for recovery from
the hepatic injury that approached normality by
day.26 Furthermore, p53 immunohistochemistry on
9 cases revealed no p53 mutations or protein
overexpression. It is believed that iron-induced
chronic oxidative stress eventually leads to mutations
in critical gatekeeping or DNA repair genes. This
view is supported by the increased lipid peroxidation
and frequency of mutations in the tumor suppressor
p53 gene, identified in nontumorous liver samples
from Hereditary hemochromatosis and Wilson
disease patients.27 Future work is expected to
identify more genes associated with effect of iron
overload and CCl
4
hepatocarcinogenesis.
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FIGURE 1. A: Control group showing normal hepatocytes (Group I). B and D: FeSO4 administered by feed and CCl4 administered by
gavage (5 days per week) for 3 weeks (Group II). C and E: FeSO4 administered by feed and CCl4 administered by gavage (5 days per
week) for III weeks and no-treatment for 2 weeks (Group III). No p53 mutations or protein overexpression. A, B, and C hematoxylin
and eosin staining; D, and E, immunostaining. Original magnification of all panels, X400.
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CONCLUSION
It was concluded that p-53 mutation was not
detected in Rattus norvegicus rats that induced
hepatocarcinogenic agent (FeSO
4
and CCl
4
) for 3
weeks and hepatic injury was still encountered in a
pause of chemical hepatocarcinogen induced showed
that the recovery was not complete.
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